Want to see NAKA full AI Analyst Report?
NAKA Stock Chart & Stats
$0.26
--
Market closed
$0.26
--
Day’s Range― - ―
52-Week Range$3.68 - $659.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.98M
Market Cap
$65.95M
Enterprise Value$4.25B
Total Cash (Recent Filing)$35.30M
Total Debt (Recent Filing)$209.74M
Price to Earnings (P/E)―
Beta4.20
Next Earnings
Aug 19, 2026EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-29.55
Shares Outstanding17,402,140
10 Day Avg. Volume32,220,503
30 Day Avg. Volume30,978,537
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.31
Price to Sales (P/S)87.61
P/FCF Ratio-6.72
Enterprise Value/Market Cap64.37
Enterprise Value/Revenue1.08K
Enterprise Value/Gross Profit-288.04
Enterprise Value/Ebitda-15.34
Forecast
1Y Price Target
$27.50Price Target Upside10476.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-8
Revenue Forecast (FY)$36.77M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA >100% TTM revenue rebound indicates the company has regained demand or market traction versus prior troughs. If sustained, higher revenues provide a foundation to leverage fixed costs, improve unit economics and support scaling investments, making future recovery in margins feasible.
Debt Restructuring And Extended MaturitiesRestructuring that extends principal maturities and cuts annual financing costs materially improves near-term liquidity and lowers refinancing risk. This creates a clearer runway to execute operational turnarounds and reduces cash outflows, supporting medium-term financial stability.
Share Repurchase Authorization & Listing ComplianceA $25M buyback authorization plus regained Nasdaq compliance reflects management confidence and provides a flexible capital-allocation tool. Maintaining listing compliance preserves access to public markets, reducing structural liquidity and governance risks for ongoing operations.
Bears Say
Negative Cash GenerationSustained negative operating and free cash flows indicate the business is burning cash to fund operations, creating a structural funding need. Persistent cash burn elevates refinancing and dilution risk, constrains reinvestment capacity, and makes long-term viability conditional on external financing or margin recovery.
Severe Profitability DeteriorationDeeply negative gross margins and a -74% net margin show core economics are currently unprofitable, implying revenue cannot cover direct costs. This structural profitability gap undermines sustainable cash generation and requires material cost reduction or pricing change to restore durable earnings power.
Balance-Sheet Fragility And Equity DeclineDeclining equity and a history of negative equity signal a fragile capital base and weak retained earnings. That reduces borrowing headroom, increases the probability of dilutive financing or covenant strain, and limits the company's resilience to shocks or prolonged operating shortfalls.
Kindly MD News
NAKA FAQ
What was Kindly MD’s price range in the past 12 months?
Kindly MD lowest stock price was $3.68 and its highest was $659.20 in the past 12 months.
What is Kindly MD’s market cap?
Kindly MD’s market cap is $65.95M.
When is Kindly MD’s upcoming earnings report date?
Kindly MD’s upcoming earnings report date is Aug 19, 2026 which is in 36 days.
How were Kindly MD’s earnings last quarter?
Kindly MD released its earnings results on May 13, 2026. The company reported -$15.2 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$15.
Is Kindly MD overvalued?
According to Wall Street analysts Kindly MD’s price is currently Undervalued.
Does Kindly MD pay dividends?
Kindly MD does not currently pay dividends.
What is Kindly MD’s EPS estimate?
Kindly MD’s EPS estimate is -0.61.
How many shares outstanding does Kindly MD have?
Kindly MD has 17,402,140 shares outstanding.
What happened to Kindly MD’s price movement after its last earnings report?
Kindly MD reported an EPS of -$15.2 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went up 8.363%.
Which hedge fund is a major shareholder of Kindly MD?
Currently, no hedge funds are holding shares in NAKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kindly MD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.50 (10476.92% Upside)
$27.50 (10476.92% Upside)
Hedge Fund Trend
Increased
By 19.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $992.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.98%
12-Months-Change
Fundamentals
Return on Equity
-84.79%
Trailing 12-Months
Asset Growth
9999.00%
Trailing 12-Months
Company Description
Kindly MD
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. The company provides commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. The company was incorporated in 2019 and is based in Nashville, Tennessee.
NAKA Stock 12 Month Forecast
Average Price Target
$27.50
▲(10476.92% Upside)
Technical Analysis
EyePoint Pharmaceuticals
―
Inhibrx Biosciences Inc
―
Rapport Therapeutics, Inc.
―
―
Beta Bionics, Inc.
―
Ownership Overview
22.29% Insiders
1.26% Mutual Funds
7.90% Other Institutional Investors
67.30% Public Companies and
Individual Investors